Drug delivery by micro-and nano-carriers enables controlled transport of pharmaceuticals to targeted sites. Even though carrier fabrication has made much progress recently, the delivery including controlled particle distribution and adhesion within the body remains a great challenge. The adhesion of carriers is strongly affected by their margination properties (migration toward walls) in the microvasculature. To investigate margination characteristics of carriers of different shapes and sizes and to elucidate the relevant physical mechanisms, we employ mesoscopic hydrodynamic simulations of blood flow. Particle margination is studied for a wide range of hematocrit values, vessel sizes, and flow rates, using two-and three-dimensional models. The simulations show that the margination properties of particles improve with increasing carrier size. Spherical particles yield slightly better margination than ellipsoidal carriers; however, ellipsoidal particles exhibit a slower rotational dynamics near a wall favoring their adhesion. In conclusion, micron-sized ellipsoidal particles are favorable for drug delivery in comparison with sub-micron spherical particles.
T he use of targeted micro-and nano-carriers for the delivery of imaging agents and drugs provides a promising strategy for early detection and treatment of diseases, e.g., of cancer 1, 2 . However, the design of particles carrying different contrast agents and drugs as well as their physical delivery are very challenging tasks. Micro-and nano-particle fabrication, which needs to address several issues such as bio-compatibility, durability, binding to specific targets, and the ability of controlled release, has been strongly advanced in recent years [3] [4] [5] [6] [7] . Nevertheless, the development of efficient strategies for the delivery of carriers, including their distribution in the organism following systemic administration 8 and their transport through biological barriers [8] [9] [10] (e.g., microvascular walls, interstitial space, and cell membranes), requires a much more detailed understanding of the relevant physical and biological mechanisms 2, 8, 11, 12 . Successful delivery of micro-and nano-carriers strongly depends on their efficient binding to specific targeted sites. Consequently, the distribution of carriers within vessel cross-sections plays an important role, since binding of carriers is only possible in case of direct particle-wall interactions. The cross-sectional distribution of microand nano-particles depends on several relevant parameters, which concern blood flow properties (such as flow rate, red blood cell deformability, and hematocrit -the volume fraction of red blood cells), vessel size, and particle characteristics (such as size, shape, and deformability). The migration of various suspended particles or cells toward walls in blood flow, which is often referred to as margination, has been observed experimentally for white blood cells 13, 14 , platelets 15, 16 , and rigid micro-particles 17, 18 . Particle margination is mediated by red blood cells (RBCs), which migrate to the vessel center 19 due to hydrodynamic interactions with the walls (called lift force) 20, 21 leading to a RBC-free layer near the walls. More precisely, the occurrence of margination is a consequence of the competition between lift forces on RBCs and suspended particles, and their interactions in flow 22 . However, the dependence of margination efficiency on particle size and shape remains largely unexplored so far.
The role of particle size and shape in the efficient delivery is a multi-faceted problem. Large enough particles with a characteristic diameter (D p ) greater than about 4 mm may become trapped in the smallest capillaries of the body 23 . In addition, recent experiments suggest that large particles with D p * w 3 mm are subject to an enhanced phagocytosis 24 . However, recent microfluidic experiments 25 have shown that spheres with the size of 2 mm show a significantly higher adhesion density than particles with a size of 200 nm and 500 nm. Other experiments 26 indicate that liposomes with D p , 70 nm and D p . 300 nm have shorter circulation times than those having an intermediate size of D p < 150-200 nm. Furthermore, nano-particles with a size below 20-30 nm are rapidly excreted through the kidneys 27 . Experiments with discoidal particles 28 have shown that they accumulate in the organs better than their spherical counterparts; however, particle internalization by macrophages appears to be worse for elongated particles 29 . Adhesion of different particles has been studied experimentally 30, 31 and theoretically 32, 33 , with the result that oblate ellipsoids are subject to stronger adhesion than spheres with the same volume. To better understand the adhesion potential of micro-and nano-particles, a quantitative description of particle margination under realistic blood flow conditions is required.
In this work, we investigate the role of particle size and shape on the margination efficiency, and therefore on their adhesion potential. Several sizes ranging from about hundred nanometers to a few micrometers and two different shapes (spherical and ellipsoidal) are considered. The margination of micro-and nano-particles is studied numerically for a wide range of hematocrit values, vessel sizes, and flow rates using a combination of two-dimensional (2D) and three-dimensional (3D) models. Our results indicate that large particles possess a larger probability of being marginated than small particles. As the particle size becomes very small (less than about 100-200 nm), the particle distribution within vessel cross-section can be described well by the plasma volume around flowing RBCs. Furthermore, spherical particles marginate better than ellipsoids, however the adhesion efficiency of ellipsoidal particles is expected to be superior in comparison to that of spheres due to their slower rotational dynamics near a wall. Finally, we discuss what size and shape of micro-and nano-carriers may be best suited for biomedical applications.
Results
Blood is modeled as a suspension of RBCs and micro-or nanoparticles, while blood flow is studied in idealized microvessels using simulations in 2D and 3D, see Fig. 1 and Methods section for details. The 3D blood model has been shown to properly capture essential properties of blood flow in microchannels 34 as well as blood rheological characteristics 35, 36 . To study micro-and nano-particle margination for a wide range of conditions, we also exploit a 2D blood flow model due to its numerical efficiency; however, we will show that the 2D model is able to qualitatively reproduce the required blood flow characteristics and the particle margination effect in comparison with the 3D model.
Blood flow characteristics. The simulated system corresponds to a cylindrical microvessel in 3D with the diameter W or to a channel in 2D with the width W. We focus here on channel width W 5 20 mm, but the cases of W 5 10 mm and W 5 40 mm are also discussed. In flow direction, periodic boundary conditions are assumed and blood flow is driven by a constant force applied to all solvent particles, which is equivalent to a prescribed pressure drop. The hematocrit H t is defined as the volume fraction of RBCs. To characterize the flow strength, we define a non-dimensional shear rate in both 2D and 3D as
where _ c~ v=W is the average shear rate (or pseudo shear rate) and v is the average flow velocity computed from the flow rate, while t defines a characteristic RBC relaxation time. Here, g is the solvent's dynamic viscosity, D r~ffi ffiffiffiffiffiffiffiffiffi ffi A 0 =p p in 3D and D r 5 L 0 /p in 2D are the corresponding RBC diameters, where A 0 is the RBC surface area in 3D and L 0 is the cell contour length in 2D, and k r is the RBC membrane bending rigidity. The RBCs are further characterized in 2D by the reduced area A Carrier positions in blood flow sampled over time lead to particle distributions, which reflect the probability of a particle to be at a certain distance from the wall. The RBC-free layer (RBCFL) thickness, which is computed from simulation snapshots through the analysis of the RBC core boundary 34 similar to experimental measurements 37 (see Supplementary Fig. S1 ), is depicted by small arrows. The distributions have been averaged over the halves of the channel due to symmetry. Figure 2 shows that the carriers migrate into the RBCFL and remain quasi-trapped there. With increasing H t , the carriers marginate better, as indicated by the development of a strong peak in the distribution near the wall at y/W 5 0, and the motion of the peak position towards the wall. This is due to a decrease in the RBCFL thickness leading to a smaller available space for the particles. This trend is in agreement with experimental observations 17 and simulations [38] [39] [40] of margination of blood platelets, which have a comparable size.
To quantify and compare particle margination for a wide range of flow and particle parameters, we define the margination probability as a fraction of particles whose center-of-mass is located within the near-wall layer of thickness d. The choice of d depends on the exact problem to be addressed, and several possibilities can be considered. To describe particle margination into the vicinity of a vessel wall, it is natural to select d to be the RBCFL thickness. Typical values of RBCFL thickness and their dependence on H t are displayed in Supplementary Fig. S2 . Figures 3(a) ,(b) present margination probability diagrams of particles for a wide range of H t and _ c Ã values corresponding to 3D and 2D simulations, respectively; the comparison shows that roughly _ c
. Particle margination strongly depends on H t as well as on shear rate. At low H t values, particle margination is expected to be weak, while at high H t the margination might be also attenuated due to particle-RBC interactions near a wall. The latter effect has been described for a marginating white blood cell 41 and is expected to subside for particles substantially smaller than a RBC, i.e. of sub-micrometer size. A pronounced dependence of particle margination on shear rate is observed at low flow rates. In the limit of very small flow rates (_ c Ã * v 1), the RBC distribution should be nearly uniform, and therefore, the RBCFL and consequently particle margination should almost vanish. As the shear rate is increased, the RBCFL thickness grows rapidly 42 , leading to a substantial increase in particle margination.
The . The considered range of shear rates is also relevant for tumor microvasculature, since blood flow velocities in tumors are much reduced in comparison to those under normal conditions, due to high geometric resistance and vessel permeability 45, 46 . Furthermore, the margination probability diagrams in
Figs. 3(a),(b) show that the strongest particle margination occurs in the range of H t 5 0.25-0.6. This region has a considerable overlap with the characteristic hematocrits in the body's microvascular networks in the range H t 5 0.2-0.4. A strong particle margination at high H t values seems to be an advantage for drug delivery to tumors, since blood within tumor microvasculature is often subject to hemoconcentration due to plasma leakage 47 . We also note that particle margination obtained from 3D simulations displays a higher margination probability at lower H t values than that in the corresponding 2D system. This difference arises from the variation in RBCFL thicknesses in 2D and 3D systems. Thus, RBCFLs in 3D tubes are thinner than those in 2D channels for the same H t values due to cylindrical curvature of the geometry, which affects close-packing of flowing RBCs. In order to relate simulations with similar RBCFL thicknesses, 3D margination data should be compared with 2D data at a larger hematocrit (by about 0.1-0.2), see Supplementary Fig. S2 . In addition, the 3D data also shows a decrease of particle margination at , where the margination probability is defined as a probability of a particle center-of-mass to be within the RBCFL. high shear rates. Nevertheless, both 2D and 3D simulations show qualitatively similar trends for the dependence of carrier margination on H t and _ c Ã . Therefore, we conclude that 2D simulations are able to properly capture particle margination properties in blood flow. Further, we will often employ a 2D system due to its robustness and low computational cost in comparison with a 3D system. Dependence of margination on particle size. The discussion above considered the margination of micron-size particles. There is also a strong interest in nano-carriers, with sizes starting from several nanometers. Figures 4(a) 83 mm) reveals that the region of high margination probability becomes smaller with decreasing particle size. To illustrate the reason for the reduction in margination probability with decreasing particle size, we present in Fig. 4 (c) the distributions of particles with different sizes for H t 5 0.3 and _ c Ã <29:3. For large enough particles, we observe a pronounced peak in the distribution next to the wall due to their interactions with RBCs, since their size is comparable with the RBCFL thickness. Even though small particles are also marginated, their distribution within the RBCFL is more uniform and their presence around the vessel center line is more probable than that for larger particles. Thus, the cumulative probability for a single particle to be within the RBCFL is lower for nano-carriers than that for microparticles. Recent in vivo experiments 48 also support our numerical observations that particles with a size of about 1 mm are located closer to the vessel wall than smaller nano-particles. Noteworthy is that the distribution of the smallest particles with D p 5 0.04D r closely approaches the distribution computed as the excess fluid volume of flowing RBCs. This indicates that the distribution of particles smaller in size than roughly 250 nm can be well approximated by the distribution of the blood plasma, and therefore, their margination properties can be directly inferred from local H t distributions.
To decide on a suitable particle size for efficient drug delivery, a number of different considerations have to be taken into account. A direct interpretation of probabilities in Figs. 3(b) and 4(a) ,(b) suggests that larger particle sizes are more favorable for drug delivery due to their better margination properties. To further support this proposition, we consider another definition for the margination probability based on
Another definition for margination probability can also be based on a fixed layer thickness d, thus it does not depend on H t or on particle size. Margination diagrams for this definition are illustrated in Supplementary Fig. S3 . Figure 5 (a) presents the margination probability into the potential adhesion layer (p s ) in 2D at _ c Ã <29:3. At very small H t , the fraction of particles within the potential adhesion layer is small for all particle sizes; however, the smallest studied particles seem to be slightly more advantageous here. Remember that the interpretation of 2D margination data for a RBCFL thickness with respect to the same RBCFL thickness in 3D requires a shift in H t values such that the range of the fraction of large particles within the potential adhesion layer is much higher than that for small particles. The corresponding margination diagrams are shown in Figs. 5(b-d) and support the conclusion that large particles marginate better for all considered shear rates. This indicates that micro-carriers are likely to be better for drug delivery than sub-micron particles.
Dependence of margination on vessel size. To elucidate the effect of vessel diameter, we performed a number of simulations in 2D for two additional channel widths (W 5 10 mm and 40 mm) and two particle sizes (D p 5 0.15D r and D p 5 0.3D r ); corresponding simulation snapshots are displayed in the Supplementary Fig. S4 . We consider margination into both the RBCFL and the potential adhesion layer. The pronounced dependence of particle margination properties on channel width for the potential adhesion layer is illustrated by a comparison of Fig. 5(b) and Fig. 6 . For particles with a size of D p 5 0.3D r (1.83 mm), particle margination into the potential adhesion layer improves considerably as the channel size decreases due to the much smaller RBCFL thickness in narrow channels. Thus, particle adhesion is expected to be more efficient in small vessels (i.e., capillaries) than in large vessels (i.e., venules and arterioles). Supplementary Fig. S5 supports this observation for particles with D p 5 0.15D r (0.91 mm). Furthermore, a reduction of margination into the potential adhesion layer with decreasing particle size is found for all channel sizes.
Particle margination based on the RBCFL thickness exhibits similar dependence on H t and flow rate for different channel widths, see Supplementary Fig. S6 . For the channel width W 5 10 mm, margination into the RBCFL differs only slightly for different particle sizes up to H t < 0.5. For H t * w 0:5, the particle radius might be larger than the RBCFL thickness, leading to an apparent decrease in margination for the large particles. For the cases W 5 20 and 40 mm, where the RBCFL thickness is always larger than the particle radius, we observe that large particles marginate clearly better than small particles. Dependence of margination on particle shape. Advances in microand nano-particle fabrication facilitate the production of carriers of various shapes, including spherical, prolate and oblate ellipsoidal, and rod-like shapes 5 . However, advantages of different particle shapes for drug delivery are still to be explored. Thus, we investigate the effect of shape on the margination properties in blood flow. Figure 7 displays results of simulations in 2D for the margination probability (based on the RBCFL) of elliptic particles under various blood flow conditions in comparison to circular particles. The ellipse has an aspect ratio of about 7 and the longest diameter is D p 5 0.63D r (3.84 mm); the enclosed area corresponds to the area of a circle with diameter D p 5 0.22D r (1.35 mm) . The plot indicates that margination of elliptic particles is slightly worse than that of circular particles. From these data we can also conclude that margination of the elliptic particles with a smaller aspect ratio than 7 is similar to that presented in Fig. 7 . However, since the largest diameter of the ellipse is larger than that of a circle with the same area, its margination into the potential adhesion layer, which is defined as a probability of a particle to be within a near-wall layer of thickness d 5 0.5D p 1 200 nm, appears to be considerably larger for ellipsoids than that for the corresponding sphere (see Fig. 5 ). We have also performed a number of 3D simulations with oblate ellipsoids having the same aspect ratio, which showed that their margination is qualitatively similar to that in 2D.
Recent theoretical 32, 33 and experimental 30, 31 studies suggest that ellipsoidal particles possess better adhesion properties than spheres due to a larger contact area for adhesion interactions. It is also interesting to consider drag force on an ellipsoid or sphere in shear flow near a wall. In case of an ellipsoid close and parallel to a wall, the drag force is found to be smaller than that on a sphere with the same volume, which was estimated in separate simulations of a sphere and an ellipsoid in shear flow with fixed position. Thus, adhered ellipsoidal particles experience a lower drag force due to fluid flow than the corresponding spheres with the same volume. In conclusion, the current knowledge about adhesion of ellipsoidal particles and our simulation results on margination suggest that ellipsoidal particles are very likely a better choice for drug delivery than spherical particles.
Dynamics of marginated particles. Local particle dynamics may also influence the margination and adhesion efficiency. Simulations in 3D show that the dynamics of marginated particles (i.e., within the RBCFL region) is different for spherical and ellipsoidal particles. A spherical particle is subject to a uniform rotation, while an ellipsoid displays tumbling dynamics. A quantitative analysis of the average angular velocities AEvae of marginated particles shows that ellipsoidal particles rotate considerably slower within the RBCFL than spherical carriers, see Fig. 8 . The comparison is made for a sphere and an ellipsoid of the same volume, while the long semiaxis of the ellipsoid is about twice the radius of the sphere. Within the RBCFL region it is plausible to assume a simple shear flow with the wall shear rate _ c w , which can be computed directly from a near-wall velocity profile or estimated from the pressure gradient applied to drive the flow. In Fig. 8 , we compare the average angular velocities of marginated spherical and ellipsoidal particles with the theoretical predictions by Jeffery 50 for an oblate ellipsoidal particle in shear flow, which is given by
where r e is the aspect ratio of major and minor axis. For a sphere, r e 5 1 which implies v s~_ c w =2, while for an ellipsoid, r e 5 7 which results in v e <0:14_ c w , such that v e , v s . In addition, while the results for AEvae in Fig. 8(a) for a sphere are close to the theoretical results, the computed angular velocities for an ellipsoid in Fig. 8(b) are lower than the corresponding theoretical predictions due to the confinement of the ellipsoid between the wall and flowing RBCs. A lower rotational velocity of a particle leads to a longer interaction time between the particle and a wall. Thus, adhesion of ellipsoidal particles is expected to be more efficient than for spheres with a comparable size. In conclusion, a detailed analysis of dynamics of marginated particles further supports the proposition that ellipsoidal particles are likely to be better candidates for drug delivery.
Discussion
Particle margination in blood flow depends on particle size and shape, hematocrit, vessel size, and flow rate. Margination of spherical and ellipsoidal particles increases with increasing hematocrit, while their margination properties appear to be rather similar, where a sphere marginates slightly more efficient than an ellipsoid. The presented diagrams show that larger particles have a higher margination probability in comparison to the smaller ones. Moreover, the distribution of very small particles with a diameter smaller than approximately 250 nm is well represented by the blood plasma volume of RBCs. Margination of particles into the potential adhesion layer is found to be more pronounced in small vessels, indicating that particle adhesion is likely to occur more often in capillaries than in arterioles and venules. The simulation results are in good qualitative agreement with several experimental observations 15, 17, 25, 30, 31, 48 . For example, margination of micro-particles has been observed to be more efficient than that of nano-particles in recent in vivo experiments 48 . However, a detailed quantitative comparison is still difficult due to two reasons. On the one hand, the majority of the simulation results is obtained for 2D systems, which provide interesting insights into the relevant mechanisms, but have limited power for quantitative predictions for 3D systems. On the other hand, experimental data on particle mar- gination in blood flow 15, 48 are very scarce and most of the available experimental investigations (e.g., Refs. 25, 30, 31) focus on carrier adhesion. Even though margination is a necessary pre-condition for particle adhesion to vessel walls, particle margination and adhesion are not equivalent, since carrier adhesion may also depend on other factors (e.g., specific targets, the receptor/ligand density and distribution).
Clearly, the size and shape of drug carriers are important parameters not only for margination, but also for their adhesion and further transport through biological barriers (e.g., internalization). Our simulations suggest that ellipsoidal particles are expected to adhere more efficiently than spherical carriers due to a larger surface for adhesive interactions and decelerated tumbling motion within the RBCFL. Therefore, our future numerical investigations will be focused on the adhesion ability of various particles in blood flow. Further requirements for efficient drug delivery include particle transport through vessel walls, interstitial space, and cell membranes. For instance, particle internalization by endothelial cells and intracellular trafficking have been shown to be most efficient for spherical sub-micron particles, rather than for micron-size carriers with an ellipsoidal shape 10 . This observation points in the direction of smaller carrier to be most efficient for internalization. As a consequence, the concept of multi-stage drug-delivery carriers 1, 7 , where a larger microparticle incorporates a number of small nano-carriers, seems to be very promising. In this way, margination and carrier delivery or adhesion to a specific target within the microvasculature could be achieved using micro-particles, which would then be followed by the release of nano-particles into the tissue. In conclusion, tackling various drug-delivery challenges is a complex issue; its resolution requires an inter-disciplinary effort including in vitro and in vivo experiments and realistic numerical simulations.
Methods
Simulation method. We employ the dissipative particle dynamics (DPD) method 51, 52 for 2D simulations and the smoothed DPD (SDPD) method 53 for 3D simulations, where both methods are mesoscopic particle-based simulation approaches which properly capture hydrodynamics. Both simulated systems are represented by a collection of n point particles. The particles interact locally within a selected cutoff region through three pairwise forces denoted as conservative (F In the SDPD method, the forces are derived by a discretization of the Navier-Stokes equation similar to the smoothed particle hydrodynamics (SPH) method 54 , while the implementation of thermal fluctuations is analogous to that in DPD 53 . The forces on particle i are given by the conservative force F Blood components. In 3D, a RBC membrane and suspended carriers are both modeled by a collection of discrete points, which are the vertices of a triangular network of springs on their membrane surface 55 . The network assumes fixed connectivity with the potential energy defined as
which includes the spring's elastic energy U spring , the bending energy U bend , and the area and volume conservation constraints U area and U vol . The spring forces mimic the elasticity of a membrane. The bending energy represents the bending resistance of a membrane, while the area and volume energies enforce area-incompressibility of a membrane and incompressibility of the inner cytosol, respectively. Boundary conditions. In the flow direction, periodic boundary conditions (BCs) were imposed, while in the other directions the suspension was confined by walls. The walls are modeled by frozen fluid particles with the same structure as the fluid, while the wall thickness is equal to r c . Thus, the interactions of fluid particles with wall particles are the same as the interactions between fluid particles, and the interactions of suspended carriers and cells with the wall are identical to those with a suspending fluid. To prevent wall penetration, fluid particles as well as vertices of RBCs and carriers are subject to reflection at the fluid-solid interface. We employed bounceback reflections, because they provide a better approximation for the no-slip boundary conditions in comparison to specular reflection of particles. To ensure that no-slip boundary conditions are strictly satisfied, we also add a tangential adaptive shear force 56 which acts on the fluid particles in a near-wall layer of a thickness h c 5 r c .
Coupling between solvent and cells/carriers. Coupling between the fluid flow and cells/carriers is achieved through viscous friction 55 between cell vertices and the surrounding fluid particles, which is implemented via the DPD interactions F D and F R for both 2D and 3D simulations. The strength c of the dissipative force F D for the interaction between a fluid particle and a membrane vertex is computed such that noslip BCs are ensured. The derivation of c is based on the idealized case of linear shear flow over a flat part of a membrane with area A. In a continuum hydrodynamics description, the total shear force exerted by the fluid on the area A is equal to Ag_ c, where g is the fluid's viscosity and _ c is the local wall shear-rate. The same fluid force has to be also transmitted onto a discrete membrane having N A vertices within the area A. The force on a single membrane vertex exerted by the sheared fluid can be found as F v~ð Vh ng r ð ÞF D dV where n is the fluid number density, g(r) is the radial distribution function of fluid particles with respect to the membrane particles, and V h is the half sphere volume of fluid above the membrane. Here, the total shear force on the area A is equal to N A F v . The equality of N A F v~A g_ c results in an expression of the dissipative force coefficient in terms of the fluid density and viscosity, wall density N A /A, and r c . Under the assumption of linear shear flow the shear rate _ c cancels out. This formulation results in satisfaction of the no-slip BCs for the linear shear flow over a flat membrane; however, it also serves as an excellent approximation for no-slip at the membrane surface. Note that conservative interactions between fluid and membrane particles are turned off, which implies that the radial distribution function is structureless, g(r) 5 1. In 2D, the surface area is replaced by a line of length L with N L particles, and the half sphere volume is replaced by the half circle area A v .
Gathering statistics. The center-of-mass distributions of particles were calculated on the fly and were written to disk as sub-averages over short time intervals. Final averaging of the data is done during post-processing. To make sure that the final averaging of data starts from a time point which is sufficiently late for the system to be independent of the initial conditions, we have tested the sensitivity of final distributions to the choice of the starting time for averaging.
Measuring RBC-free-layer thickness. To determine the RBC-free-layer (RBCFL) thickness, we measure the outer edge of the RBC core shown in Supplementary Fig.  S1 , which is similar to RBCFL measurements in experiments 37, 57 . The data are averaged for many RBC snapshots at different times. In 3D, the RBC core edge is measured by projecting RBC vertices onto the x-y plane, where curves of the RBC core minimum and maximum are fitted similar to that in Supplementary Fig. S1 . Here, we also perform averaging over different angular orientations (to exploit the cylindrical symmetry of the channel) in addition to the temporal averaging.
